| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exotropia | 4 | 2023 | 23 | 2.010 |
Why?
|
| Strabismus | 2 | 2023 | 213 | 1.550 |
Why?
|
| Phosphoprotein Phosphatases | 10 | 2021 | 214 | 1.540 |
Why?
|
| Proto-Oncogene Proteins c-akt | 16 | 2023 | 2054 | 1.450 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2023 | 425 | 1.330 |
Why?
|
| RNA Helicases | 3 | 2022 | 101 | 1.100 |
Why?
|
| Receptors, Androgen | 5 | 2023 | 878 | 0.970 |
Why?
|
| Hepatitis B | 3 | 2015 | 258 | 0.940 |
Why?
|
| MAP Kinase Signaling System | 4 | 2021 | 848 | 0.910 |
Why?
|
| Hepatitis B virus | 2 | 2015 | 217 | 0.880 |
Why?
|
| GATA2 Transcription Factor | 1 | 2022 | 68 | 0.850 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 160 | 0.830 |
Why?
|
| Viral Proteins | 2 | 2015 | 435 | 0.830 |
Why?
|
| Signal Transduction | 29 | 2024 | 11965 | 0.830 |
Why?
|
| Esotropia | 1 | 2022 | 54 | 0.830 |
Why?
|
| PAX6 Transcription Factor | 1 | 2021 | 53 | 0.820 |
Why?
|
| Aniridia | 1 | 2021 | 17 | 0.810 |
Why?
|
| Interleukin-8 | 4 | 2020 | 519 | 0.790 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 5767 | 0.780 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2019 | 14 | 0.730 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2023 | 1678 | 0.710 |
Why?
|
| MicroRNAs | 8 | 2022 | 2947 | 0.690 |
Why?
|
| Diterpenes | 1 | 2019 | 111 | 0.690 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 249 | 0.610 |
Why?
|
| Cell Line, Tumor | 25 | 2023 | 14551 | 0.600 |
Why?
|
| Atherosclerosis | 2 | 2024 | 935 | 0.600 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 854 | 0.600 |
Why?
|
| Retinitis Pigmentosa | 2 | 2014 | 79 | 0.600 |
Why?
|
| Commiphora | 2 | 2013 | 2 | 0.580 |
Why?
|
| Hepatocytes | 6 | 2021 | 351 | 0.570 |
Why?
|
| NF-kappa B | 3 | 2024 | 1549 | 0.550 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 268 | 0.550 |
Why?
|
| Smad Proteins | 1 | 2016 | 88 | 0.530 |
Why?
|
| Abnormalities, Multiple | 1 | 2021 | 998 | 0.510 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2016 | 243 | 0.500 |
Why?
|
| Apoptosis | 12 | 2021 | 7591 | 0.500 |
Why?
|
| TOR Serine-Threonine Kinases | 11 | 2022 | 1546 | 0.490 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 4053 | 0.480 |
Why?
|
| Cell Proliferation | 11 | 2022 | 7226 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2023 | 8873 | 0.470 |
Why?
|
| Bardet-Biedl Syndrome | 1 | 2013 | 38 | 0.470 |
Why?
|
| Triterpenes | 1 | 2013 | 61 | 0.460 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1129 | 0.450 |
Why?
|
| DNA, Viral | 1 | 2015 | 694 | 0.440 |
Why?
|
| Androgen Antagonists | 4 | 2023 | 411 | 0.430 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2024 | 1538 | 0.430 |
Why?
|
| Epithelial Cells | 1 | 2019 | 1818 | 0.420 |
Why?
|
| cdc25 Phosphatases | 1 | 2012 | 97 | 0.420 |
Why?
|
| T-Box Domain Proteins | 2 | 2015 | 156 | 0.410 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 1390 | 0.410 |
Why?
|
| Phosphorylation | 16 | 2016 | 4804 | 0.400 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2012 | 311 | 0.380 |
Why?
|
| China | 4 | 2023 | 606 | 0.380 |
Why?
|
| Cell Movement | 7 | 2022 | 2466 | 0.370 |
Why?
|
| HEK293 Cells | 5 | 2021 | 1489 | 0.370 |
Why?
|
| Myocytes, Cardiac | 2 | 2017 | 764 | 0.370 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 1084 | 0.360 |
Why?
|
| Colorectal Neoplasms | 3 | 2022 | 3578 | 0.360 |
Why?
|
| Mice | 24 | 2024 | 34495 | 0.350 |
Why?
|
| Interleukin-6 | 6 | 2024 | 1038 | 0.340 |
Why?
|
| RNA Interference | 7 | 2020 | 1408 | 0.340 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 852 | 0.340 |
Why?
|
| Animals | 31 | 2024 | 59536 | 0.330 |
Why?
|
| Lung | 1 | 2019 | 3151 | 0.320 |
Why?
|
| Humans | 58 | 2023 | 261506 | 0.320 |
Why?
|
| Phenotype | 5 | 2024 | 6295 | 0.320 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2022 | 986 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2023 | 639 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 473 | 0.310 |
Why?
|
| Mutation | 4 | 2015 | 15179 | 0.310 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2022 | 973 | 0.300 |
Why?
|
| Pyridones | 3 | 2016 | 348 | 0.300 |
Why?
|
| Macrophages | 3 | 2024 | 1304 | 0.300 |
Why?
|
| Reactive Oxygen Species | 6 | 2020 | 987 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 11 | 2024 | 6942 | 0.280 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 610 | 0.270 |
Why?
|
| Cardiotoxicity | 2 | 2017 | 155 | 0.250 |
Why?
|
| Blotting, Western | 10 | 2015 | 3536 | 0.250 |
Why?
|
| Polysaccharides | 2 | 2017 | 197 | 0.250 |
Why?
|
| Smad1 Protein | 2 | 2014 | 35 | 0.250 |
Why?
|
| DNA Mutational Analysis | 3 | 2015 | 2283 | 0.250 |
Why?
|
| Androgens | 3 | 2023 | 511 | 0.240 |
Why?
|
| Cell Line | 11 | 2017 | 5114 | 0.240 |
Why?
|
| Open Reading Frames | 2 | 2015 | 250 | 0.240 |
Why?
|
| Vision, Binocular | 2 | 2022 | 71 | 0.240 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2021 | 107 | 0.240 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 1 | 2023 | 14 | 0.240 |
Why?
|
| Histone Deacetylase 2 | 1 | 2023 | 35 | 0.230 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2023 | 41 | 0.230 |
Why?
|
| Rhabdomyosarcoma | 3 | 2016 | 341 | 0.230 |
Why?
|
| Gene Frequency | 3 | 2015 | 1163 | 0.230 |
Why?
|
| Interleukin-13 | 1 | 2024 | 135 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2359 | 0.230 |
Why?
|
| Kallikreins | 2 | 2021 | 84 | 0.230 |
Why?
|
| Interleukin-4 | 1 | 2024 | 284 | 0.230 |
Why?
|
| Oculomotor Muscles | 2 | 2022 | 179 | 0.220 |
Why?
|
| PPAR gamma | 1 | 2024 | 229 | 0.220 |
Why?
|
| Cell Differentiation | 5 | 2023 | 4078 | 0.220 |
Why?
|
| Mice, SCID | 3 | 2022 | 1869 | 0.210 |
Why?
|
| Sirolimus | 3 | 2012 | 814 | 0.210 |
Why?
|
| Heart Failure | 2 | 2017 | 2516 | 0.210 |
Why?
|
| Smad3 Protein | 2 | 2013 | 129 | 0.210 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2021 | 301 | 0.200 |
Why?
|
| Enzyme Activation | 5 | 2019 | 1764 | 0.200 |
Why?
|
| Nitrogen | 2 | 2014 | 162 | 0.200 |
Why?
|
| Flavonoids | 2 | 2020 | 188 | 0.200 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2020 | 18 | 0.190 |
Why?
|
| Cadmium | 2 | 2011 | 57 | 0.190 |
Why?
|
| Eye | 1 | 2023 | 301 | 0.190 |
Why?
|
| Gene Expression | 4 | 2019 | 3570 | 0.190 |
Why?
|
| Finasteride | 1 | 2020 | 31 | 0.190 |
Why?
|
| Insulin Resistance | 2 | 2017 | 731 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2022 | 3821 | 0.190 |
Why?
|
| Neuropeptides | 1 | 2021 | 154 | 0.190 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2016 | 413 | 0.190 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2022 | 177 | 0.190 |
Why?
|
| Protein Phosphatase 2C | 3 | 2016 | 75 | 0.190 |
Why?
|
| Cyclin B1 | 1 | 2020 | 56 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2021 | 190 | 0.180 |
Why?
|
| Sodium Compounds | 1 | 2019 | 6 | 0.180 |
Why?
|
| Cholesterol, LDL | 1 | 2024 | 565 | 0.180 |
Why?
|
| Arsenites | 1 | 2019 | 18 | 0.180 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 3343 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 3 | 2014 | 1130 | 0.180 |
Why?
|
| Anoikis | 2 | 2022 | 63 | 0.180 |
Why?
|
| Chemokine CCL20 | 1 | 2019 | 39 | 0.180 |
Why?
|
| Eye Proteins | 1 | 2021 | 269 | 0.180 |
Why?
|
| Liver | 4 | 2017 | 2961 | 0.180 |
Why?
|
| Male | 23 | 2023 | 123000 | 0.180 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 158 | 0.180 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 993 | 0.170 |
Why?
|
| Pedigree | 2 | 2021 | 1890 | 0.170 |
Why?
|
| Caspase 3 | 3 | 2020 | 471 | 0.170 |
Why?
|
| Immunoprecipitation | 3 | 2016 | 591 | 0.170 |
Why?
|
| Exome | 2 | 2014 | 1239 | 0.170 |
Why?
|
| Glycogen | 2 | 2015 | 80 | 0.160 |
Why?
|
| Autophagy | 3 | 2020 | 927 | 0.160 |
Why?
|
| Doxorubicin | 2 | 2017 | 3005 | 0.160 |
Why?
|
| Multiprotein Complexes | 3 | 2016 | 395 | 0.160 |
Why?
|
| Cell Cycle | 3 | 2013 | 2084 | 0.160 |
Why?
|
| Computational Biology | 2 | 2015 | 1271 | 0.160 |
Why?
|
| Protein Kinase C | 1 | 2019 | 396 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2023 | 1819 | 0.150 |
Why?
|
| Child | 6 | 2023 | 29154 | 0.150 |
Why?
|
| Gluconeogenesis | 1 | 2017 | 121 | 0.150 |
Why?
|
| Heart Function Tests | 1 | 2017 | 73 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 3981 | 0.150 |
Why?
|
| RNA, Messenger | 3 | 2024 | 6150 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2023 | 16273 | 0.140 |
Why?
|
| Retroviridae | 1 | 2017 | 332 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2016 | 2216 | 0.140 |
Why?
|
| Antioxidants | 1 | 2019 | 507 | 0.140 |
Why?
|
| Genotype | 2 | 2015 | 4109 | 0.140 |
Why?
|
| Chemokine CXCL13 | 1 | 2015 | 21 | 0.140 |
Why?
|
| Isoleucine-tRNA Ligase | 1 | 2015 | 1 | 0.140 |
Why?
|
| Receptors, CXCR5 | 1 | 2015 | 27 | 0.140 |
Why?
|
| Databases, Genetic | 2 | 2020 | 745 | 0.140 |
Why?
|
| Cytosol | 1 | 2016 | 238 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2021 | 1152 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 182 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 1143 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 703 | 0.130 |
Why?
|
| Interferon-gamma | 1 | 2020 | 1144 | 0.130 |
Why?
|
| Codon, Terminator | 1 | 2015 | 42 | 0.130 |
Why?
|
| Neurons | 3 | 2011 | 2287 | 0.130 |
Why?
|
| Twist-Related Protein 1 | 1 | 2016 | 127 | 0.130 |
Why?
|
| Leukocyte Common Antigens | 1 | 2015 | 188 | 0.130 |
Why?
|
| Glycogenolysis | 1 | 2015 | 11 | 0.130 |
Why?
|
| Molecular Structure | 2 | 2013 | 515 | 0.130 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 193 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 750 | 0.130 |
Why?
|
| Endoderm | 1 | 2015 | 55 | 0.130 |
Why?
|
| Astragalus Plant | 1 | 2014 | 1 | 0.130 |
Why?
|
| Activins | 1 | 2015 | 98 | 0.130 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2017 | 221 | 0.130 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2015 | 212 | 0.130 |
Why?
|
| Cholestasis | 1 | 2017 | 203 | 0.130 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2014 | 29 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 2594 | 0.120 |
Why?
|
| Transfection | 2 | 2017 | 2944 | 0.120 |
Why?
|
| Smad8 Protein | 1 | 2014 | 9 | 0.120 |
Why?
|
| Cytokines | 1 | 2024 | 2809 | 0.120 |
Why?
|
| Serine | 1 | 2016 | 388 | 0.120 |
Why?
|
| Animals, Genetically Modified | 2 | 2016 | 406 | 0.120 |
Why?
|
| Smad5 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 598 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 1439 | 0.120 |
Why?
|
| Plant Exudates | 1 | 2013 | 1 | 0.120 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2013 | 11 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2020 | 1493 | 0.120 |
Why?
|
| Artemisinins | 1 | 2013 | 13 | 0.120 |
Why?
|
| Quinoxalines | 1 | 2014 | 95 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 803 | 0.120 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2013 | 110 | 0.120 |
Why?
|
| Thioredoxins | 1 | 2013 | 50 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2012 | 630 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 229 | 0.110 |
Why?
|
| Adolescent | 6 | 2023 | 31252 | 0.110 |
Why?
|
| Amino Acid Motifs | 3 | 2020 | 392 | 0.110 |
Why?
|
| Zebrafish | 2 | 2016 | 463 | 0.110 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 163 | 0.110 |
Why?
|
| In Vitro Techniques | 1 | 2016 | 1618 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 367 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 598 | 0.110 |
Why?
|
| Caspase 9 | 1 | 2013 | 189 | 0.110 |
Why?
|
| Neoplasms | 3 | 2023 | 15193 | 0.110 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 62 | 0.110 |
Why?
|
| Protein Binding | 3 | 2014 | 3438 | 0.110 |
Why?
|
| Phylogeny | 1 | 2015 | 826 | 0.110 |
Why?
|
| Rats | 5 | 2014 | 6086 | 0.110 |
Why?
|
| Dietary Supplements | 1 | 2017 | 558 | 0.110 |
Why?
|
| Nickel | 1 | 2012 | 44 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 301 | 0.110 |
Why?
|
| I-kappa B Kinase | 2 | 2016 | 250 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2012 | 15 | 0.110 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 5112 | 0.100 |
Why?
|
| Genes, Reporter | 2 | 2011 | 798 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 1215 | 0.100 |
Why?
|
| Ion Transport | 1 | 2011 | 79 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2017 | 574 | 0.100 |
Why?
|
| Copper | 1 | 2012 | 165 | 0.100 |
Why?
|
| Smad2 Protein | 1 | 2011 | 89 | 0.100 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 268 | 0.100 |
Why?
|
| Glucose | 1 | 2017 | 1248 | 0.100 |
Why?
|
| Terpenes | 1 | 2011 | 34 | 0.100 |
Why?
|
| RNA | 1 | 2016 | 1013 | 0.100 |
Why?
|
| Sesquiterpenes | 1 | 2011 | 68 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2014 | 825 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 1487 | 0.090 |
Why?
|
| Ion Channels | 1 | 2011 | 212 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 577 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 518 | 0.090 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 79 | 0.090 |
Why?
|
| Rats, Wistar | 1 | 2011 | 562 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 1555 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 291 | 0.090 |
Why?
|
| Phytotherapy | 1 | 2011 | 110 | 0.090 |
Why?
|
| Cholesterol | 1 | 2013 | 658 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 83 | 0.090 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 88 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 1265 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2022 | 37905 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2020 | 2819 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2018 | 2074 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 492 | 0.090 |
Why?
|
| Cells, Cultured | 5 | 2017 | 5637 | 0.090 |
Why?
|
| Cytoskeleton | 1 | 2010 | 267 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 217 | 0.090 |
Why?
|
| Prostate | 1 | 2014 | 1088 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 521 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 1833 | 0.080 |
Why?
|
| DNA Damage | 2 | 2018 | 1954 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 14889 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 548 | 0.080 |
Why?
|
| Pyrroles | 1 | 2012 | 576 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 2437 | 0.080 |
Why?
|
| Liver Neoplasms | 2 | 2015 | 4557 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 3639 | 0.080 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2016 | 265 | 0.080 |
Why?
|
| Soil | 1 | 2008 | 48 | 0.080 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 15694 | 0.080 |
Why?
|
| Software | 1 | 2015 | 1321 | 0.080 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 14289 | 0.080 |
Why?
|
| Phosphorus | 1 | 2008 | 65 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 1271 | 0.080 |
Why?
|
| Binding Sites | 1 | 2011 | 2171 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 672 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2010 | 726 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3033 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2008 | 173 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 1217 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2022 | 32848 | 0.070 |
Why?
|
| Mice, Obese | 2 | 2017 | 104 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2015 | 10331 | 0.070 |
Why?
|
| Young Adult | 5 | 2016 | 21445 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2013 | 806 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2016 | 5710 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2011 | 1620 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 3552 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2012 | 1048 | 0.070 |
Why?
|
| Glycogen Synthase Kinases | 2 | 2015 | 12 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1077 | 0.070 |
Why?
|
| Phosphoproteins | 4 | 2013 | 1152 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 2291 | 0.070 |
Why?
|
| Female | 13 | 2022 | 141928 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 1223 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3230 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2020 | 460 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2019 | 4307 | 0.060 |
Why?
|
| Random Allocation | 2 | 2016 | 703 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2018 | 528 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2023 | 23 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 2027 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2016 | 371 | 0.060 |
Why?
|
| Base Sequence | 3 | 2017 | 4917 | 0.060 |
Why?
|
| Disease Progression | 1 | 2014 | 6682 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 2927 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2014 | 334 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5061 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1374 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2017 | 716 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2020 | 2450 | 0.050 |
Why?
|
| Dutasteride | 1 | 2020 | 10 | 0.050 |
Why?
|
| Adult | 6 | 2020 | 77950 | 0.050 |
Why?
|
| Obesity | 1 | 2013 | 2884 | 0.050 |
Why?
|
| PC12 Cells | 2 | 2010 | 46 | 0.050 |
Why?
|
| Chromones | 1 | 2020 | 120 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 5539 | 0.050 |
Why?
|
| NADP | 1 | 2020 | 96 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2011 | 5270 | 0.050 |
Why?
|
| Ubiquitination | 1 | 2023 | 575 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 133 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2010 | 131 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 131 | 0.050 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 184 | 0.050 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2020 | 56 | 0.050 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 134 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2020 | 181 | 0.040 |
Why?
|
| Risk Factors | 4 | 2017 | 17523 | 0.040 |
Why?
|
| Morpholines | 1 | 2020 | 289 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2020 | 253 | 0.040 |
Why?
|
| Oligoribonucleotides | 1 | 2017 | 10 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2017 | 11 | 0.040 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2017 | 23 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2019 | 348 | 0.040 |
Why?
|
| Antagomirs | 1 | 2017 | 19 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 6207 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2020 | 251 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 73 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 15862 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2017 | 29 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 167 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 5395 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2012 | 889 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 163 | 0.040 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2017 | 48 | 0.040 |
Why?
|
| Sendai virus | 1 | 2016 | 6 | 0.040 |
Why?
|
| Vesiculovirus | 1 | 2016 | 17 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2016 | 32 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 673 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2016 | 93 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 1313 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 718 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 1643 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 677 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 155 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 234 | 0.030 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2015 | 132 | 0.030 |
Why?
|
| Fetal Proteins | 1 | 2015 | 28 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2020 | 652 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 241 | 0.030 |
Why?
|
| SOXF Transcription Factors | 1 | 2015 | 34 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 297 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 507 | 0.030 |
Why?
|
| Quantum Theory | 1 | 2014 | 11 | 0.030 |
Why?
|
| Imines | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cyclization | 1 | 2014 | 21 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2017 | 215 | 0.030 |
Why?
|
| Pteridines | 1 | 2014 | 34 | 0.030 |
Why?
|
| Middle Aged | 6 | 2020 | 86204 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 383 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2020 | 1385 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 314 | 0.030 |
Why?
|
| Hydrogen | 1 | 2014 | 58 | 0.030 |
Why?
|
| Cell Survival | 2 | 2011 | 3045 | 0.030 |
Why?
|
| Phenylthiohydantoin | 1 | 2014 | 89 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 634 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 370 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 875 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 248 | 0.030 |
Why?
|
| Carbon | 1 | 2014 | 149 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2014 | 182 | 0.030 |
Why?
|
| Oxides | 1 | 2014 | 211 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 664 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 392 | 0.030 |
Why?
|
| Teichoic Acids | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2013 | 25 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 275 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 303 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 1048 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2013 | 164 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2015 | 269 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 446 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 2045 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 323 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 844 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1165 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 148 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2017 | 1338 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 1062 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2012 | 164 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 404 | 0.030 |
Why?
|
| Catalysis | 1 | 2012 | 250 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2014 | 370 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 278 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 886 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 566 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2016 | 873 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2015 | 436 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 3101 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2015 | 1681 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2010 | 35 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1454 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 370 | 0.020 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2010 | 42 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2010 | 95 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 323 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 234 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2010 | 28 | 0.020 |
Why?
|
| Receptors, Somatomedin | 1 | 2010 | 70 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 992 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 549 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 558 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 196 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2010 | 146 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1987 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 342 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 1742 | 0.020 |
Why?
|
| Family | 1 | 2014 | 736 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 49 | 0.020 |
Why?
|
| Nitriles | 1 | 2014 | 906 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2010 | 116 | 0.020 |
Why?
|
| Androstadienes | 1 | 2010 | 165 | 0.020 |
Why?
|
| Acetylcysteine | 1 | 2010 | 143 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 202 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 2063 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 644 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 198 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2010 | 160 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2010 | 331 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 335 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2010 | 249 | 0.020 |
Why?
|
| Benzamides | 1 | 2014 | 1832 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2015 | 1011 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 284 | 0.020 |
Why?
|
| Cyclins | 1 | 2010 | 456 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 2508 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2010 | 324 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 1090 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2014 | 834 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 9180 | 0.020 |
Why?
|
| Time Factors | 2 | 2015 | 12926 | 0.020 |
Why?
|
| Diffusion | 1 | 2008 | 88 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 148 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 1694 | 0.020 |
Why?
|
| Prognosis | 2 | 2017 | 21713 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2013 | 1459 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 29902 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 264 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 534 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 4744 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 611 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 4988 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4892 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 337 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 5673 | 0.020 |
Why?
|
| Aged | 3 | 2020 | 70117 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 4320 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 11538 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 2314 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2015 | 4844 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 4938 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2017 | 2992 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 6100 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 4143 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7222 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10001 | 0.010 |
Why?
|
| Biomarkers | 1 | 2015 | 5047 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5159 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 3254 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 5178 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2010 | 2022 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 1963 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2330 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5542 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13310 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 4757 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 10035 | 0.010 |
Why?
|